{"id":613483,"date":"2026-09-15T12:57:29","date_gmt":"2026-09-15T12:57:29","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/613483\/on-the-pen-launches-redesigned-glp1-news-website-as-independent-media-platform-expands.html"},"modified":"2026-09-15T12:57:29","modified_gmt":"2026-09-15T12:57:29","slug":"on-the-pen-launches-redesigned-glp1-news-website-as-independent-media-platform-expands","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/613483\/on-the-pen-launches-redesigned-glp1-news-website-as-independent-media-platform-expands.html","title":{"rendered":"On The Pen Launches Redesigned GLP-1 News Website as Independent Media Platform Expands"},"content":{"rendered":"
\n
Dave Knapp, founder and CEO of On The Pen announces a redesigned GLP-1 news website, expanding its independent coverage of obesity medicine, diabetes, metabolic health and the pharmaceutical industry.<\/div>\n<\/div>\n
On The Pen has launched a redesigned OnThePen.com, strengthening its position as a destination for GLP-1 news, obesity medicine coverage and patient-centered reporting. The platform is also home to On The Pen: The Weekly Dose Podcast, a top-ranked, award-winning GLP-1 podcast in the top 0.5% of all podcasts globally.<\/div>\n

CEDAR FALLS, Iowa – September 15, 2026 –<\/strong> On The Pen, an independent GLP-1 news and media platform covering obesity medicine, diabetes, metabolic health and the pharmaceutical industry, has launched a redesigned version of OnThePen.com.<\/p>\n

The refresh gives On The Pen a cleaner, more traditional digital newsroom with improved navigation, stronger breaking-news presentation and easier access to written reporting, podcasts, livestreams and video coverage.<\/p>\n

The redesigned site expands On The Pen’s role as a destination for top-ranked GLP-1 news<\/strong>, including coverage of Ozempic, Wegovy, Mounjaro, Zepbound, retatrutide, clinical trials, drug pricing, access, insurance, telehealth, compounding and pharmaceutical industry developments.<\/p>\n

“On The Pen started because there was a deficit of information that actually spoke to them,” said founder Dave Knapp. “The new site gives that reporting a stronger home and makes it easier for people to understand what is happening in GLP-1 medicine and what it could mean for them.”<\/p>\n

The website also gives greater prominence to On The Pen: The Weekly Dose Podcast<\/strong>, a top-ranked, award-winning GLP-1 podcast in the top 0.5% of all podcasts globally<\/strong>.<\/p>\n

Together, the website, podcast and live programming position On The Pen as an independent multimedia source for GLP-1 news, obesity medicine coverage and patient-centered reporting<\/strong>.<\/p>\n

About On The Pen<\/strong><\/p>\n

On The Pen is an independent GLP-1 news and media platform covering GLP-1 medications, obesity medicine, diabetes, metabolic health and the pharmaceutical industry. The platform publishes breaking GLP-1 news, original reporting, analysis, livestreams and On The Pen: The Weekly Dose Podcast. Its mission is to empower patients to have better conversations with their doctors.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> OTP MEDIA CORP<\/a>
Contact Person:<\/strong> Ann.Metz
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 3193000840
Address:<\/strong>3045 Capital Way #5 Stge 201-G
City:<\/strong> Cedar Falls
State:<\/strong> IA
Country:<\/strong> United States
Website:<\/strong> www.onthepen.com<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Dave Knapp, founder and CEO of On The Pen announces a redesigned GLP-1 news website, expanding its independent coverage of obesity medicine, diabetes, metabolic health and the pharmaceutical industry. On<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/613483"}],"collection":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/comments?post=613483"}],"version-history":[{"count":0,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/613483\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/media?parent=613483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/categories?post=613483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/tags?post=613483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}